Company: WAL-PA
Filing Date: 2025-05-01
Form Type: 10-Q
Source: 0001212545-25-000141
Chunk: 120

Company: WESTERN ALLIANCE BANCORPORATION
Filing Date: 2025-05-01
Form: 10-Q
Item: Part I, Item 1
Chunk 120
---
656 659 Preferred stock295 295 Noncontrolling interest in subsidiary293 — Total tangible common stockholders' equity5,971 5,753 Plus: deferred tax - attributed to intangible assets2 2 Total tangible common equity, net of tax$5,973 $5,755 Total assets$83,043 $80,934 Less: goodwill and intangible assets, net656 659 Tangible assets82,387 80,275 Plus: deferred tax - attributed to intangible assets2 2 Total tangible assets, net of tax$82,389 $80,277 Tangible common equity ratio7.2 %7.2 %Common shares outstanding110.4 110.1 Book value per common share$60.03 $58.24 Tangible book value per common share, net of tax54.10 52.27 

Three Months Ended March 31,20252024(dollars in millions)Net income available to common stockholders$195.9 $174.2 Divided by:Average stockholders' equity$6,899 $6,184 Less:Average goodwill and intangible assets658 668 Average preferred stock295 295 Average noncontrolling interest in subsidiary16 — Average tangible common equity$5,930 $5,221 Return on average tangible common equity13.4 %13.4 %

63

Regulatory Capital

The following table presents certain financial measures related to regulatory capital under Basel III, which includes CET1 and total capital. The FRB and other banking regulators use CET1 and total capital as a basis for assessing a bank's capital adequacy; therefore, management believes it is useful to assess financial condition and capital adequacy using this same basis. Specifically, the total capital ratio takes into consideration the risk levels of assets and off-balance sheet financial instruments. In addition, management believes that the classified assets to CET1 plus allowance measure is an important regulatory metric for assessing asset quality. 

As permitted by the regulatory capital rules, the Company elected the CECL transition option that delayed the estimated impact on regulatory capital resulting from the adoption of CECL over a five-year transition period that ended December 31, 2024. Accordingly, capital ratios and amounts for 2024 included a 25% capital benefit that resulted from the increased ACL related to the adoption of ASC 326. This capital benefit was